The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Proteome analysis of human substantia nigra in Parkinson's disease
Open accessAbstract
Protein expression has been compared in human substantia nigra specimens from Parkinson's disease (PD) patients and from controls, and 44 proteins expressed in this midbrain region were identified by peptide mass fingerprinting. Among them, nine showed changes in their abundance. L and M neurofilament chains are less abundant in PD specimens, whereas peroxiredoxin II, mitochondrial complex III, ATP synthase D chain, complexin I, profilin, L‐type calcium channel δ‐subunit, and fatty‐acid binding protein are significantly more present in PD samples than in controls. Besides the consolidated view of oxidative stress involvement in PD pathogenesis, suggested by overexpression of mitochondrial and reactive oxygen species (ROS)‐scavenging proteins, these results indicate a possible potentiation mechanism of afferent signals to substantia nigra following degeneration of dopaminergic neurons.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Oxidants, oxidative stress and the biology of ageing
Finkel, T., & Holbrook, N. J. (2000) · Nature · doi:10.1038/35041687 · Cited by 9,413
Spillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240
AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease
Krüger, R., Kuhn, W., Müller, T., Woitalla, D., Graeber, M., Kösel, S., Przuntek, H., Epplen, J. T., Schols, L., & Riess, O. (1998) · Nature Genetics · doi:10.1038/ng0298-106 · Cited by 3,836
Oxidative stress in Parkinson's disease
Jenner, P. (2003) · Annals of Neurology · doi:10.1002/ana.10483 · Cited by 2,053
Lang, A. E., & Lozano, A. M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810083391506 · Cited by 1,994
The ubiquitin pathway in Parkinson's disease
Leroy, E., Boyer, R., Auburger, G., Leube, B., Ulm, G., Mezey, E., Harta, G., Brownstein, M. J., Jonnalagada, S., Chernova, T., et al. (1998) · Nature · doi:10.1038/26652 · Cited by 1,571
Conway, K. A., Lee, S.-J., Rochet, J.-C., Ding, T. T., Williamson, R. E., & Lansbury, P. T. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.2.571 · Cited by 1,541
Alpha-synuclein and neurodegenerative diseases
Goedert, M. (2001) · Nature Reviews Neuroscience · doi:10.1038/35081564 · Cited by 1,408
Oxidative stress and nitration in neurodegeneration: Cause, effect, or association?
Ischiropoulos, H., & Beckman, J. S. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17638 · Cited by 747
α-Synuclein Fibrillogenesis Is Nucleation-dependent
Wood, S. J., Wypych, J., Steavenson, S., Louis, J.-C., Citron, M., & Biere, A. L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.28.19509 · Cited by 720
Both Familial Parkinson's Disease Mutations Accelerate α-Synuclein Aggregation
Narhi, L., Wood, S. J., Steavenson, S., Jiang, Y., Wu, G. M., Anafi, D., Kaufman, S. A., Martin, F., Sitney, K., Denis, P., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.14.9843 · Cited by 710
Tanaka, Y. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.9.919 · Cited by 497
Molecular Basis of the Neurodegenerative Disorders
Martin, J. B. (1999) · New England Journal of Medicine · doi:10.1056/nejm199906243402507 · Cited by 418
Aberrant expression of peroxiredoxin subtypes in neurodegenerative disorders
Krapfenbauer, K., Engidawork, E., Cairns, N., Fountoulakis, M., & Lubec, G. (2003) · Brain Research · doi:10.1016/s0006-8993(02)04243-9 · Cited by 287
DJ-1 is an indicator for endogenous reactive oxygen species elicited by endotoxin
Mitsumoto, A., & Nakagawa, Y. (2001) · Free Radical Research · doi:10.1080/10715760100301381 · Cited by 287
Lotharius, J. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.20.2395 · Cited by 269
Mitsumoto, A., Nakagawa, Y., Takeuchi, A., Okawa, K., Iwamatsu, A., & Takanezawa, Y. (2001) · Free Radical Research · doi:10.1080/10715760100300831 · Cited by 257
(2002) · doi:10.1016/s0304-3940(02)00016-2 · Cited by 225
An immunohistochemical study on α‐ketoglutarate dehydrogenase complex in Parkinson's disease
Mizuno, Y., Matuda, S., Yoshino, H., Mori, H., Hattori, N., & Ikebe, S. (1994) · Annals of Neurology · doi:10.1002/ana.410350212 · Cited by 199
Expression of mutant alpha-synuclein causes increased susceptibility to dopamine toxicity
Tabrizi, S. J. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.18.2683 · Cited by 197
Mitochondrial involvement in Parkinson's disease
Orth, M. (2002) · Neurochemistry International · doi:10.1016/s0197-0186(01)00124-3 · Cited by 188
Schönberger, S. J., Edgar, P. F., Kydd, R. R., Faull, R. L. M., & Cooper, G. J. S. (2001) · PROTEOMICS · doi:10.1002/1615-9861(200111)1:12<1519::aid-prot1519>3.0.co;2-l · Cited by 187
Pocernich, C. B., Cardin, A. L., Racine, C. L., Lauderback, C. M., & Allan Butterfield, D. (2001) · Neurochemistry International · doi:10.1016/s0197-0186(01)00012-2 · Cited by 183
Sinha, P., Poland, J., Schnölzer, M., & Rabilloud, T. (2001) · PROTEOMICS · doi:10.1002/1615-9861(200107)1:7<835::aid-prot835>3.0.co;2-2 · Cited by 179
(2000) · doi:10.1016/s0306-4522(00)00077-4 · Cited by 167
Mitochondrial function, GSH and iron in neurodegeneration and Lewy body diseases
Gu, M., Owen, A. D., Toffa, S. E. K., Cooper, J. M., Dexter, D. T., Jenner, P., Marsden, C. D., & Schapira, A. H. V. (1998) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(98)00095-1 · Cited by 164
Mizuno, Y., Suzuki, K., & Ohta, S. (1990) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(90)90056-s · Cited by 130
Variants of peroxiredoxins expression in response to hydroperoxide stress
Mitsumoto, A., Takanezawa, Y., Okawa, K., Iwamatsu, A., & Nakagawa, Y. (2001) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00503-7 · Cited by 119
Cookson, M. (2003) · Neuron · doi:10.1016/s0896-6273(02)01166-2 · Cited by 96
Pathobiology of the Lewy body.
Je, G., Vm, L., Schmidt, M. L., Ph, T., Iwatsubo, T., & Trojanowski, J. Q. (1999) · PubMed · Cited by 86
Free Radicals in Brain Pathophysiology
Poli, G. (2000) · CRC Press eBooks · doi:10.1201/9781482270167 · Cited by 73
Harhangi, B. S., Farrer, M. J., Lincoln, S., Bonifati, V., Meco, G., Michele, G. D., Brice, A., Dürr, A., Martinez, M. M., Gasser, T., et al. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00465-6 · Cited by 72
Alpha-synuclein and Parkinson's disease
Golbe, L. I. (1999) · Movement Disorders · Cited by 64
L-type calcium channels in the hippocampus and cerebellum of Alzheimer's disease brain tissue.
Coon, A., Wallace, D., Mactutus, C., & Booze, R. (1999) · Neurobiology of Aging · doi:10.1016/s0197-4580(99)00068-8 · Cited by 56
Sealed with a twist: complexin and the synaptic SNARE complex
Marz, K. E., & Hanson, P. I. (2002) · Trends in Neurosciences · doi:10.1016/s0166-2236(02)02207-5 · Cited by 44
Schulz, J. B., & DICHGANS, J. (1999) · Current Opinion in Neurology · doi:10.1097/00019052-199908000-00010 · Cited by 39
L ‐Dihydroxyphenylalanine and complex I deficiency in Parkinson's disease brain
Cooper, J. A. D., Daniel, S. E., MARSDEN, C. D., & Schapira, A. H. V. (1995) · Movement Disorders · doi:10.1002/mds.870100311 · Cited by 37
Lopiano, L., Fasano, M., Giraudo, S., Digilio, G., Koenig, S. H., Torre, E., Bergamasco, B., & Aime, S. (2000) · Neurochemistry International · doi:10.1016/s0197-0186(00)00036-x · Cited by 30
Self-citationProteome analysis of mesencephalic tissues: evidence for Parkinson?s disease
Basso, M., Giraudo, S., Lopiano, L., Bergamasco, B., Bosticco, E., Cinquepalmi, A., & Fasano, M. (2003) · Neurological Sciences · doi:10.1007/s10072-003-0106-2 · Cited by 21
Self-citationStructure/function in neuroprotection and apoptosis
Borden, K. L. B. (1998) · Annals of Neurology · doi:10.1002/ana.410440711 · Cited by 21
Cited by
Microglia and inflammation-mediated neurodegeneration: Multiple triggers with a common mechanism
Block, M. L., & Hong, J.-S. (2005) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2005.06.004 · Cited by 1,557
Hanschmann, E.-M., Godoy, J. R., Berndt, C., Hudemann, C., & Lillig, C. H. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.4599 · Cited by 677
Chong, Z. Z., Li, F., & Maiese, K. (2005) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2005.02.004 · Cited by 536
Lipid peroxidation and neurodegenerative disease
Reed, T. T. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.06.027 · Cited by 379
Nrf2—a therapeutic target for the treatment of neurodegenerative diseases
Johnson, D. A., & Johnson, J. A. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.07.147 · Cited by 321
Metadata
- Authors
- Basso, M., Giraudo, S., Corpillo, D., Bergamasco, B., Lopiano, L., & Fasano, M.
- Venue
- PROTEOMICS
- Publisher
- Wiley
- Published
- 2004-12
- Volume
- 4
- Issue
- 12
- Pages
- 3943-3952
- ISSN
- 1615-9853 (ISSN-L)
- 1615-9861
- OpenAlex
- W2000156275
- Cited by
- 271
- References
- 41
- FWCI
- 8.44
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.